Skip to main content

Table 1 General characteristics of the participants (n = 942)

From: Dutch women’s intended participation in a risk-based breast cancer screening and prevention programme: a survey study identifying preferences, facilitators and barriers

  All women
N = 942
Low risk
N = 236
Average risk
N = 228
Moderate risk
N = 239
High risk
N = 239
Age (years), mean (SD) 59.0 (6.3) 58.7 (6.3) 58.6 (6.5) 58.9 (5.9) 59.8 (6.3)
Education level, n (%)
 Lower education 249 (26.4) 65 (27.6) 58 (25.4) 63 (26.4) 63 (26.4)
 Higher secondary education 372 (39.5) 82 (34.7) 97 (42.5) 96 (40.2) 97 (40.6)
 Higher vocational qualification 321 (34.1) 89 (37.7) 73 (32.1) 80 (33.4) 79 (33.0)
Marital status, n living with partner (%) 729 (77.3) 187 (79.2) 180 (78.9) 188 (78.7) 174 (72.8)
First-degree family history breast cancer, n yes (%) 204 (21.7) 47 (19.9) 52 (22.8) 47 (19.7) 58 (24.3)
Body mass index (kg/m2), mean (SD)a 26.3 (4.8) 26.5 (4.9) 26.1 (4.6) 26.6 (5.5) 26.0 (4.1)
Medical condition, n ≥ 2 diagnosed (%)b 424 (45.0) 119 (50.4) 96 (42.1) 103 (43.1) 106 (44.4)
Current medication use, n yes (%) 391 (41.5) 109 (46.2) 85 (37.3) 91 (38.1) 106 (44.4)
Current MHTc use, n yes (%) 33 (3.5) 9 (3.8) 5 (2.2) 12 (5.0) 7 (3.0)
Benign breast disease, n yes (%) 272 (28.9) 79 (33.5) 64 (28.1) 68 (28.5) 61 (25.5)
Perceived breast cancer risk (%)
 Low 182 (19.3) 48 (20.3) 44 (19.3) 47 (19.7) 43 (18.0)
 Below average 186 (19.7) 45 (19.1) 49 (21.5) 40 (16.7) 52 (21.8)
 Average 498 (52.9) 126 (53.4) 121 (53.1) 130 (54.4) 121 (50.6)
 Moderate 54 (5.7) 10 (4.2) 10 (4.4) 16 (6.7) 18 (7.5)
 High 5 (0.5) 2 (0.8) 1 (0.4) 1 (0.4) 1 (0.4)
 Missing value 17 (1.8) 5 (2.1) 3 (1.3) 5 (2.1) 4 (1.7)
General health score, mean (SD) 82.1 (14.2) 81.3 (14.4) 81.7 (15.5) 83.8 (12.8) 81.5 (13.9)
Life events, n ≥ 2 (%)d 264 (28.0) 74 (31.4) 64 (28.1) 63 (26.4) 63 (26.4)
HLOCe, n (%)
 Internal 300 (31.8) 78 (33.1) 69 (30.3) 73 (30.5) 80 (33.5)
 Physician 67 (7.1) 11 (4.7) 11 (4.8) 27 (11.3) 18 (7.5)
 Chance 447 (47.5) 115 (48.7) 111 (48.7) 107 (44.8) 114 (47.7)
 No clear preference 113 (12.0) 29 (12.3) 34 (14.9) 27 (11.3) 23 (9.6)
 Missing value 15 (1.6) 3 (1.3) 3 (1.3) 5 (2.1) 4 (1.7)
Belief in medicines, mean (SD)
 Harm 9.0 (2.5) 9.0 (2.5) 9.2 (26.7) 9.0 (2.5) 9.0 (2.5)
 Overuse 11.5 (3.3) 11.6 (3.3) 11.6 (3.4) 11.6 (3.3) 11.3 (3.3)
Health anxiety, mean (SD) 7.7 (4.0) 7.6 (4.1) 7.7 (3.8) 7.6 (3.8) 7.8 (4.2)
  1. a7 women with missing value (0.7%); b ≥ 2 medical diagnosis to indicate co-morbidity; c MHT = menopausal hormone therapy; d ≥ 2 life events to enable meaningful group comparisons; e HLOC = health locus of control